PROLIFERATIVE VITREORETINOPATHY

PROLIFERATIVE VITREORETINOPATHY was reported 11 times

PROLIFERATIVE VITREORETINOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BODY CLEANSER 1 0.0014
1 DIFLUPREDNATE OPHTHALMIC 1 0.0011
2 BALANCED SALT SOLUTION 1 0.0008
3 TROPICAMIDE 1 0.0006
4 SKIN PROTECTANT 1 0.0004
5 DIFLUPREDNATE 1 0.0003
6 BEVACIZUMAB-AWWB 1 0.0002
7 PERFLUTREN 1 0.0002
8 FARICIMAB 1 0.0001
9 AFLIBERCEPT 3 0.0001
10 PREDNISOLONE ACETATE 1 0.0001
11 VALGANCICLOVIR 1 0.0001
12 MOXIFLOXACIN HYDROCHLORIDE 1 0.0000
13 MYCOPHENILIC ACID 1 0.0000
14 RANIBIZUMAB 1 0.0000
15 MYCOPHENOLIC ACID 1 0.0000
16 NEBIVOLOL HYDROCHLORIDE 1 0.0000
17 GLIMEPIRIDE 1 0.0000
18 ADALIMUMAB-FKJP 1 0.0000
19 ADALIMUMAB-AATY 1 0.0000
20 ADALIMUMAB-ADAZ 1 0.0000
21 CYCLOSPORINE 2 0.0000
22 BEVACIZUMAB 2 0.0000
23 APIXABAN 1 0.0000
24 EMPAGLIFLOZIN 1 0.0000
25 TACROLIMUS OINTMENT 0.1% 1 0.0000
26 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
27 DEXAMETHASONE 2 0.0000
28 TACROLIMUS 1 0.0000
29 PREDNISONE 2 0.0000
30 DEXAMETHASONE 1.5 MG 1 0.0000
31 METHOTREXATE SODIUM 1 0.0000
32 ADALIMUMAB 1 0.0000